Effects of Paired Associative Nerve Stimulation on Spinal Cord Injury Subjects

January 27, 2023 updated by: Lai chien hung, Taipei Medical University Hospital

Development and Application of a Novel Neurorehabilitation Technology With Paired Associative Nerve Stimulation in Spinal Cord Injured Subjects

This study is to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) combined with trans-spinal electrical stimulation (tsES) intervention on cortical excitability, brain structure, motor ability of lower limb in individuals with incomplete spinal cord injury. Twelve participants will be recruited in this study.

Study Overview

Detailed Description

Spinal cord injury (SCI) impairs motor and sensory function and affects numerous body functions and daily activities. Insufficient central nervous system plasticity can result in maladaptive changes that prevent full recovery. It's a challenge to guide this plasticity to optimize the functional outcome for individuals with SCI.

Transcranial magnetic stimulation (TMS) and trans-spinal electric stimulation (tsES) may modulate cortical excitability, corticospinal output and spinal circuit. However, few studies investigated the effectiveness of paired nerve stimulation (PNS) on neuroplasticity and functional outcome in persons with SCI. Therefore, this study aim to examine the effects of the combination of these two different non-invasive nerve stimulation with the cycling exercise on the motor cortex and corticospinal circuit excitability as well as functional recovery.

Present study clarifies the effects of five different settings of combined with TMS and tsES intervention and then undergo cycling exercise after PNS on spinal cord and cortical excitability in SCI participants.

It is expected that this project will successfully establish a new neuromodulation technology to enhance cortical, corticospinal and spinal circuit excitability as well as to improve the outcome of lower-limb function and quality of life in persons with SCI. Therefore, this project can not only publish scientific papers, but also can enhance the neuroplasticity and improve function in persons with SCI.

Study Type

Interventional

Enrollment (Anticipated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • Recruiting
        • Taipei Medical University Hospital
        • Contact:
          • Chien-Hung Lai

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age 20 to 65 years incomplete SCI (American Spinal Injury Association Impairment Scale (ASIA) B to D)
  2. Lesion area above the tenth thoracic vertebra (T10)
  3. Injury time more than one year
  4. Without range of motion (ROM) limitation
  5. Medical condition stable

Exclusion Criteria:

  1. Having pacemaker, cochlear implants, metal in the brain or skull, open wound of brain, or history of epilepsy.
  2. Having seizure history
  3. Having other neurological, mental, medical problems affect this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: rTMS (Brain) + tsES (Spinal)

First part 20 Hz rTMS (Brain) + Anode tsDCS (Spinal)

Brain:

  1. Train pulse: 2 sec
  2. Inter-train: 28 sec
  3. Total time: 1200 sec

Spinal:

Continuous direct current (DC): 1200 sec

Second part iTBS rTMS(Brain) + 2.5-mA tsDCS (Spinal)

Brain:

  1. Train pulse: 2 sec
  2. Inter-train: 8 sec
  3. Total time: 200 sec

Spinal:

Continuous direct current (DC): 600 sec

Higher frequency (>5 Hz) trains increase cortical excitability.
Anodal tsDCS increased the spinal reflex amplitude, as well as corticospinal excitability.
Experimental: rTMS (Brain) + tsES (Spinal) or sham stimulation

First part 20 Hz rTMS (Brain) + 20 Hz current square-wave pulses (Spinal)

Brain and spinal:

  1. Train pulse: 2 sec
  2. Inter-train: 28 sec
  3. Total time: 1200 sec

Second part iTBS rTMS(Brain) + sham 2.5-mA tsDCS (Spinal)

Brain:

  1. Train pulse: 2 sec
  2. Inter-train: 8 sec
  3. Total time: 200 sec

Spinal:

Sham direct current (DC) stimulation

Higher frequency (>5 Hz) trains increase cortical excitability.
Higher frequency (>5 Hz) of current increase cortical excitability.
Experimental: iTBS rTMS or sham (Brain) + tsES or sham (Spinal)

First part

Brain:

  1. Train pulse: 2 sec
  2. Inter-train: 8 sec
  3. Total time: 200 sec

Spinal:

Continuous direct current (DC): 190 sec

Second part Sham iTBS rTMS (Brain) + 2.5-mA tsDCS (Spinal)

Sham iTBS rTMS Brain:

Spinal:

Continuous direct current (DC): 600 sec

Anodal tsDCS increased the spinal reflex amplitude, as well as corticospinal excitability.
Intermittent theta burst stimulation (iTBS) is a newer rTMS approach.
Experimental: iTBS rTMS or sham (Brain) + iTBS or sham (Spinal)

First part

Brain and spinal:

  1. Train pulse: 2 sec
  2. Inter-train: 8 sec
  3. Total time: 200 sec

Second part Sham iTBS rTMS (Brain) + Sham 2.5-mA tsDCS (Spinal)

Brain:

Sham iTBS rTMS

Spinal:

Sham direct current (DC) stimulation

Intermittent theta burst stimulation (iTBS) is a newer rTMS approach.
Intermittent theta-burst stimulation (iTBS) is a newer approach. it may increase corticospinal excitability.
Sham Comparator: sham (no stimulation on brain nor spinal)

First part Sham stimulation.

No second part

with sham stimulation on brain and spinal.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Motor evoked potentials (MEP)
Time Frame: Just before the intervention start and immediately after the intervention finished.
Motor evoked potential (MEP) is recorded from tibialis anterior muscles following direct transcranial magnetic stimulation (TMS) of motor cortex. All TMS is delivered with the participant seated upright on the chair. Both passive and active conditions, participants are instructed to relax their one hand in the seated position. TMS is delivered over the motor cortex (M1) using a concave double cone coil (Magstim Co., United Kingdom) attached to a BiStim magnetic stimulator (Magstim Co., United Kingdom). To locate the optimized site, stimuli are delivered over various points around the Cz (approximate 1 cm distance from Cz). The optimal site is the location around the Cz that evoked the greatest MEP amplitude in tibialis anterior muscles. The onset latency and onset to peak amplitude will be assessed.
Just before the intervention start and immediately after the intervention finished.
Change of resting motor threshold (RMT)
Time Frame: Just before the intervention start and immediately after the intervention finished.
Resting motor threshold (RMT) is recorded from tibialis anterior muscles following transcranial magnetic stimulation. TMS is delivered over the motor cortex (M1) using a concave double cone coil (Magstim Co., United Kingdom) attached to a BiStim magnetic stimulator (Magstim Co., United Kingdom). To locate the optimal site, stimuli are delivered over various points around the Cz (the distance approximate 1 cm from Cz) to get the hot spot point. And then measure the RMT using the minimum stimulus intensity that produced a minimal motor evoked response (about 50 micro-volts (µV) in at least 5 of 10 trials) at rest.
Just before the intervention start and immediately after the intervention finished.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Modified Ashworth Scale (MAS)
Time Frame: Just before the intervention start and immediately after the intervention finished.

Modified Ashworth scale (MAS) measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity. Scoring is recorded as follows:

0: No increase in muscle tone

  1. Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension 1+: Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the Range of motion (ROM)
  2. More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved
  3. Considerable increase in muscle tone, passive movement difficult
  4. Affected part(s) rigid in flexion or extension
Just before the intervention start and immediately after the intervention finished.
Change of Lower Extremities Motor Score (LEMS)
Time Frame: Just before the intervention start and immediately after the intervention finished.

The voluntary muscle strength of five key muscles (hip flexors, knee extensors, ankle dorsiflexors, long toe extensors and ankle plantarflexors) of both lower extremities was tested.

Each muscle was given a value between 0 and 5 according to the strength of voluntary muscle contraction.

Maximum and minimum LEMS were 50 and 0, respectively.

Just before the intervention start and immediately after the intervention finished.
Change of functional Magnetic Resonance Imaging (fMRI)
Time Frame: Immediately after the intervention finished.
Our study will use 3 Tesla (T) magnetic resonance imaging[GE DISCOVERY MR750w system (GE Healthcare, Milwaukee, Wisconsin)] for functional magnetic resonance imaging. Resting-state functional MRI image is an echo-planar Image (EPI) technique, using a parameter time of repetition of 2500 milliseconds, time of echo is 30 milliseconds, 43 axial slices, slice thickness is 3 mm, flip angle is 80 degrees, field of view is 192 × 192 mm, and vixen size is 3 × 3 × 3 mm. The EPI scan for 525 seconds. All subjects are asked to close their eyes and supine. Our study uses the fractional amplitude of low-frequency fluctuations analysis to confirm abnormal brain function.
Immediately after the intervention finished.
Change of Surface Electromyography (sEMG)
Time Frame: Just before the intervention start and immediately after the intervention finished.

sEMG recordings using pairs of 1 cm-diameter silver/silver chloride recessed sEMG electrodes placed over the muscle bellies 3 cm apart were made from the right and left quadriceps (mainly rectus femoris) and hamstrings.

Electrodes were centered on the long axis over muscle bellies for recording during voluntary motor tasks performed by 30 min cycling exercise.

The 4 sEMG channels were recorded with a bandwidth of 30 to 500 Hz and a gain of 1,000. Movement sensor and event cue marker outputs were also recorded and, along with the sEMG, were continually digitized at a rate of 2,000 samples/s for the duration of the protocol.

Just before the intervention start and immediately after the intervention finished.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 9, 2019

Primary Completion (Anticipated)

September 30, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

December 5, 2019

First Submitted That Met QC Criteria

December 10, 2019

First Posted (Actual)

December 11, 2019

Study Record Updates

Last Update Posted (Actual)

January 31, 2023

Last Update Submitted That Met QC Criteria

January 27, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on 20 Hz rTMS (Brain)

3
Subscribe